Detalhe da pesquisa
1.
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia.
Blood
; 142(19): 1647-1657, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441846
2.
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage.
Cancer
; 2024 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38896064
3.
Phase 1/2 study of CPX-351 for patients with Int-2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents.
Br J Haematol
; 204(3): 898-909, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946611
4.
Effect of Digital Health Coaching on Self-Efficacy and Patient Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled Trial.
Acta Haematol
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861934
5.
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
Cancer
; 129(4): 560-568, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458426
6.
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
Br J Haematol
; 203(4): 581-592, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608562
7.
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.
Am J Hematol
; 98(10): E281-E284, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515433
8.
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
Am J Hematol
; 98(11): 1780-1790, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665752
9.
Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.
Mycoses
; 66(12): 1029-1034, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550272
10.
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia.
Am J Hematol
; 97(12): 1560-1567, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087091
11.
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations.
Acta Haematol
; 145(5): 529-536, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717939
12.
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes.
Cancer
; 127(19): 3552-3565, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161603
13.
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome.
Br J Haematol
; 195(3): 378-387, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340254
14.
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management.
Am J Hematol
; 95(11): 1399-1420, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744763
15.
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome.
Hematol Oncol
; 37(1): 96-102, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153704
16.
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
Am J Hematol
; 98(4): E91-E94, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661399
17.
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS).
Am J Hematol
; 96(7): E246-E249, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811786
18.
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3).
Am J Hematol
; 95(12): E326-E329, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886803
19.
Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery.
Nanotechnology
; 25(44): 445101, 2014 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25302488
20.
Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome.
Clin Lymphoma Myeloma Leuk
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777652